1. Home
  2. XYL vs STE Comparison

XYL vs STE Comparison

Compare XYL & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xylem Inc. New

XYL

Xylem Inc. New

HOLD

Current Price

$104.06

Market Cap

25.0B

Sector

Industrials

ML Signal

HOLD

Logo STERIS plc (Ireland)

STE

STERIS plc (Ireland)

BUY

Current Price

$208.39

Market Cap

21.3B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
XYL
STE
Founded
2011
1985
Country
United States
United States
Employees
N/A
3700
Industry
Fluid Controls
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.0B
21.3B
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
XYL
STE
Price
$104.06
$208.39
Analyst Decision
Buy
Buy
Analyst Count
21
9
Target Price
$153.88
★ $263.13
AVG Volume (30 Days)
★ 2.3M
549.2K
Earning Date
10-27-2026
11-04-2026
Dividend Yield
★ 1.68%
1.31%
EPS Growth
7.40
★ 27.90
EPS
1.90
★ 7.93
Revenue
★ $9,035,000,000.00
$5,935,900,000.00
Revenue This Year
$1.89
$7.35
Revenue Next Year
$4.61
$6.36
P/E Ratio
$53.99
★ $26.66
Revenue Growth
5.52
★ 8.73
52 Week Low
$98.58
$195.14
52 Week High
$154.27
$269.44

Technical Indicators

Market Signals
Indicator
XYL
STE
Relative Strength Index (RSI) 41.97 36.90
Support Level N/A $208.29
Resistance Level $125.73 $220.39
Average True Range (ATR) 2.43 3.70
MACD 0.06 0.61
Stochastic Oscillator 48.93 51.50

Price Performance

Historical Comparison
XYL
STE

About XYL Xylem Inc. New

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $9 billion in revenue in 2025.

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.

Share on Social Networks: